Left Atrial Appendage Occlusion Versus Novel Oral Anticoagulation for Stroke Prevention in Atrial Fibrillation

NCT03642509 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

750

Enrollment

OTHER

Sponsor class

Conditions

Atrial Fibrillation
Stroke

Interventions

DEVICE: Left atrial appendage occlusion
DRUG: NOAC

Sponsor

University of Aarhus

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]